Does a Diagnosis of Myelogenous Leukemia Require 20% Marrow Myeloblasts, and Does <5% Marrow Myeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia

Marshall A. Lichtman; International Agency for Research on Cancer; Dreyfus B; Chevallier P; Bernard J; Dreyfus B; Galton DAG; Lichtman MA; Bessis M; Killman S‐A; Bessis M; Lichtman MA; Laszlo J; Holland JF; Leisveld JL

10.1634/theoncologist.2013-0099

Does a Diagnosis of Myelogenous Leukemia Require 20% Marrow Myeloblasts, and Does <5% Marrow Myeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia

Authors: Marshall A. Lichtman
International Agency for Research on Cancer
Dreyfus B
Chevallier P
Bernard J
Dreyfus B
Galton DAG
Lichtman MA
Bessis M
Killman S‐A
Bessis M
Lichtman MA
Laszlo J
Holland JF
Leisveld JL
Publication date
Publisher: 'Alphamed Press'

Abstract

Abstract is not available.

Similar works

Full text

Crossref

Full text is not available

Last time updated on 12/3/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.